COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.
Jan 25, 2022
0
2
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.
Jan 24, 2022
0
10
Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can't get adequate protection from vaccination.
Dec 9, 2021
0
6
In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School of Medicine appears to offer long-lasting protection from COVID-19.
Nov 12, 2021
0
76
Pfizer says its antiviral COVID treatment Paxlovid cuts the chance of ending up in hospital or dying by 89%.
Nov 12, 2021
0
22
COVID-19 vaccine choices are getting more complicated. So don't feel bad if you are confused about the different COVID-19 vaccines and who's eligible for what. In addition to the three original vaccines approved by the Food ...
Oct 8, 2021
0
41
Australia currently has drugs that treat the symptoms of COVID, and drugs which have been repurposed from other diseases. Now the government has placed an early order for a new drug, sotrovimab, which works on COVID-19 virus ...
Aug 9, 2021
0
38
Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time, part of a nationwide effort to salvage expiring shots to battle the nation's ...
Jul 30, 2021
0
36
(HealthDay)—Two major U.S. health systems say they will not administer the controversial new Alzheimer's drug Aduhelm.
Jul 15, 2021
0
1
Federal officials said Wednesday they plan to strengthen cautions about a rare side effect of some COVID-19 vaccines—chest pain and heart inflammation, mostly among teenagers and young adults.
Jun 24, 2021
0
2
